Navigation Links
Human Genome Sciences Appoints Maxine Gowen, Ph.D., to Its Board Of Directors
Date:2/21/2008

ROCKVILLE, Md., Feb. 21 /PRNewswire-FirstCall/ -- Human Genome Sciences, Inc. (Nasdaq: HGSI) today announced that Maxine Gowen, Ph.D., President and Chief Executive Officer of Trevena, Inc., a privately held drug discovery company, has been appointed to the HGS Board of Directors. Prior to joining Trevena, Dr. Gowen spent 15 years at GlaxoSmithKline (GSK), where she held a series of executive management positions in drug discovery and development, and led the GSK venture capital subsidiary, S.R. One.

(Logo: http://www.newscom.com/cgi-bin/prnh/20010612/HGSLOGO )

"Maxine Gowen brings significant leadership experience to HGS in drug discovery, biotechnology venture capital investing, and business development," said H. Thomas Watkins, President and Chief Executive Officer, HGS. "She has a distinguished record of accomplishment, and we are honored to have her join our Board of Directors. We look forward to benefiting from Maxine's experience and insight in the years ahead."

Trevena, which Dr. Gowen currently heads, is based in Berwyn, Pennsylvania, and is focused on the discovery and development of novel agents that target G-protein coupled receptors, a family of cell surface receptors with many functions, including immune responses and the regulation of cellular growth and reproduction. Prior to joining Trevena, Dr. Gowen was Senior Vice President of GSK's Center of Excellence for External Drug Discovery. In that position, Dr. Gowen built and led a new R&D division with a mission to create a drug discovery portfolio through business development alliances with innovative healthcare companies. She joined GSK in 1992 to lead the Musculoskeletal
'/>"/>

SOURCE Human Genome Sciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Human Genome Sciences to Sponsor Conference Call to Discuss Full Year 2007 Financial Results
2. ARIUS presents new findings showing therapeutic antibody inhibits human leukemic cancer stem cells
3. CryoLife Receives FDA 510(k) Clearance for SynerGraft(R) Processed Human Pulmonary Heart Valves
4. Human Genome Sciences and Xencor Announce Antibody Collaboration
5. Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Merrill Lynch Conference
6. Stemagen First to Create Cloned Human Embryos From Adult Cells
7. EVICEL(TM) Fibrin Sealant (Human) Approved for General Hemostasis in Surgery
8. International team identifies 480 genes that control human cell division
9. Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at JPMorgan Conference
10. Department of Health & Human Services Names Dr. Eric Rose to National Biodefense Science Board
11. Human Genome Sciences and Aegera Therapeutics Announce Licensing and Collaboration Agreement on Novel Anti-Cancer Drugs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2014)... , Sept. 18, 2014  U.S. biotech company ... signing an exclusive license for technology developed by the ... gene expression in plants, including for applications in production ... The technology was developed under the direction ... at Kultevat and former president of the Danforth Plant ...
(Date:9/18/2014)... , Pennsylvanie, 18 septembre 2014 ... en 1974, a été depuis 40 ... les évaluations cliniques traditionnelles par des évaluations ... et sur les impacts économiques des traitements. ... A cours d,une récente ...
(Date:9/18/2014)... dysplasia is a group of rare diseases that ... cartilage. Its onset hits at the fetal stage ... in the gene encoding fibroblast growth factor receptor ... of skeletal dysplasia, thanatophoric dysplasia (TD), a skeletal ... and is often lethal, and achondroplasia (ACH), which ...
(Date:9/18/2014)... everything we touch in the course of a ... even medicines, rely on the chemical industry to ... and farm products into valuable chemicals that are ... scientist Dr Sarina Sarina, who achieved outstanding progress ... at ambient temperature using light instead of fossil ...
Breaking Biology Technology:Kultevat obtains license of gene switch technology 21974 - 2014 - Mapi fĂȘte ses 40 ans 2Researchers use iPS cells to show statin effects on diseased bone 2Researchers use iPS cells to show statin effects on diseased bone 3Using solar energy to turn raw materials into ingredients for every day life 2
... Sangart, Inc., a privately held biopharmaceutical company focused ... today announced the receipt of approximately $50 million in ... the exercise of warrants issued by Sangart as part ... The most recent investment brings the total funding ...
... WEST CONSHOHOCKEN, Pa., March 12 GEL Interactive ... today it will launch the most recent version of ... NV, March 23-25. GEL will be located in Booth ... its comprehensive event intelligence platform.GEL,s Immerse platform enables customers ...
... Inc. (TSX:SDI) today announced its operational highlights and financial ... , "In 2008, we accomplished several key objectives on ... sepsis for the U.S. market," said Dr. Paul Walker, ... to key terms with Toray Industries, Inc. (Toray) of ...
Cached Biology Technology:Sangart, Inc. Completes Series F Funding Round 2Cadient Group's GEL Interactive Technologies to Launch Immerse(SM) Exhibit 4.0 at EXHIBITOR2009 2Spectral announces 2008 financial results 2Spectral announces 2008 financial results 3Spectral announces 2008 financial results 4Spectral announces 2008 financial results 5Spectral announces 2008 financial results 6Spectral announces 2008 financial results 7Spectral announces 2008 financial results 8
(Date:9/17/2014)... Fauna Europaea started in 2000 as an EC-FP5 four-year ... years of steady progress and successful participations in several ... European Biodiversity Observation Network project (EU BON), to ... the contributors and to extend the general dissemination of ... Journal has applied its novel e-Publishing tools ...
(Date:9/17/2014)... plastic shopping bags and their environmental impact recently scored ... first statewide ban on the bags, and Governor Jerry ... bag industry is not yielding without a fight, according ... , the weekly newsmagazine of the American Chemical Society. ... that the anti-bag campaign logged its first small victory ...
(Date:9/17/2014)... Spanish researchers have obtained the first partial genome sequence ... pig found at the site of the Montsoriu Castle ... pig is closely related to today,s Iberian pig. Researchers ... with modern Iberian pigs. , The study, published in ... of pig species, and particularly on that of the ...
Breaking Biology News(10 mins):Contributions on Fauna Europaea: Data papers as innovative model on expert involvement 2Iberian pig genome remains unchanged after 5 centuries 2
... -- Scientists from The Forsyth Institute and Kings College, ... community, the Human Oral Microbiome Database, which provides descriptions ... commonly found in peoples mouths. Most bacteria living ... maintaining the health of teeth and gums, as well ...
... a biosensing nanodevice developed by Arizona State University ... airport security checkpoints and revolutionize health screenings for ... aureus (MRSA). Even more incredible than the ... the worlds tiniest rotary motor: a biological engine ...
... ... covert data -, LAKE WORTH, Fla., March 24 ... produce the,world,s first self-authenticating passport. It was introduced in the new,Belgian passport ... produces the Belgian passport,has added an optical decoder page in the passport ...
Cached Biology News:Scientists launch human oral microbiome database 2Biosensing nanodevice to revolutionize health screenings 2Biosensing nanodevice to revolutionize health screenings 3FCO and GSSC Team to Create World's First Self-Authenticating Passport 2